» Articles » PMID: 36102252

Health Care Usage Among Adolescents With Congenital Heart Defects at 5 Sites in the United States, 2011 to 2013

Abstract

Background We sought to characterize health care usage for adolescents with congenital heart defects (CHDs) using population-based multisite surveillance data. Methods and Results Adolescents aged 11 to 18 years with ≥1 CHD-related diagnosis code and residing in 5 US sites were identified in clinical and administrative data sources for the years 2011 to 2013. Sites linked data on all inpatient, emergency department (ED), and outpatient visits. Multivariable log-binomial regression models including age, sex, unweighted Charlson comorbidity index, CHD severity, cardiology visits, and insurance status, were used to identify associations with inpatient, ED, and outpatient visits. Of 9626 eligible adolescents, 26.4% (n=2543) had severe CHDs and 21.4% had Charlson comorbidity index >0. At least 1 inpatient, ED, or outpatient visit was reported for 21%, 25%, and 96% of cases, respectively. Cardiology visits, cardiac imaging, cardiac procedures, and vascular procedures were reported for 38%, 73%, 10%, and 5% of cases, respectively. Inpatient, ED, and outpatient visits were consistently higher for adolescents with severe CHDs compared with nonsevere CHDs. Adolescents with severe and nonsevere CHDs had higher health care usage compared with the 2011 to 2013 general adolescent US population. Adolescents with severe CHDs versus nonsevere CHDs were twice as likely to have at least 1 inpatient visit when Charlson comorbidity index was low (Charlson comorbidity index =0). Adolescents with CHDs and public insurance, compared with private insurance, were more likely to have inpatient (adjusted prevalence ratio, 1.5 [95% CI, 1.3-1.7]) and ED (adjusted prevalence ratio, 1.6 [95% CI, 1.4-1.7]) visits. Conclusions High resource usage by adolescents with CHDs indicates a substantial burden of disease, especially with public insurance, severe CHDs, and more comorbidities.

Citing Articles

Healthcare consumption in congenital heart disease: A temporal life-course perspective following pediatric cases to adulthood.

Pardhan S, Mandalenakis Z, Giang K, Fedchenko M, Eriksson P, Dellborg M Int J Cardiol Congenit Heart Dis. 2024; 11:100440.

PMID: 39713573 PMC: 11657615. DOI: 10.1016/j.ijcchd.2023.100440.

References
1.
Tutarel O, Kempny A, Alonso-Gonzalez R, Jabbour R, Li W, Uebing A . Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Eur Heart J. 2013; 35(11):725-32. DOI: 10.1093/eurheartj/eht257. View

2.
Wray J, Frigiola A, Bull C . Loss to specialist follow-up in congenital heart disease; out of sight, out of mind. Heart. 2012; 99(7):485-90. PMC: 3595142. DOI: 10.1136/heartjnl-2012-302831. View

3.
DHoore W, Bouckaert A, Tilquin C . Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol. 1996; 49(12):1429-33. DOI: 10.1016/s0895-4356(96)00271-5. View

4.
Arth A, Tinker S, Simeone R, Ailes E, Cragan J, Grosse S . Inpatient Hospitalization Costs Associated with Birth Defects Among Persons of All Ages - United States, 2013. MMWR Morb Mortal Wkly Rep. 2017; 66(2):41-46. PMC: 5657658. DOI: 10.15585/mmwr.mm6602a1. View

5.
Edelson J, Rossano J, Griffis H, Dai D, Faerber J, Ravishankar C . Emergency Department Visits by Children With Congenital Heart Disease. J Am Coll Cardiol. 2018; 72(15):1817-1825. DOI: 10.1016/j.jacc.2018.07.055. View